What is amiodarone injection used for?

Pharmaceutical Product Monograph: Amiodarone Hydrochloride Injection (50 mg/mL)

In the pharmaceutical industry, Amiodarone is a potent Class III antiarrhythmic agent. As a pharmacist and manufacturer, I view this molecule as a “Broad-Spectrum Electrophysiological Stabilizer”—it is technically unique because, while classified as Class III, it possesses characteristics of all four Vaughan-Williams classes (I, II, III, and IV).

At your WHO-GMP facility in Mumbai, Amiodarone injection is a critical “Life-Saving” SKU. It is reserved for acute, life-threatening rhythmic disturbances where rapid pharmacological intervention is mandatory.

Therapeutic Profile: Critical Indications

Amiodarone injection is used primarily for the acute treatment and prophylaxis of frequently recurring ventricular arrhythmias.

IndicationClinical ContextTechnical Rationale
Ventricular Fibrillation (VF)Pulseless ArrestUsed during ACLS (Advanced Cardiovascular Life Support) when VF is unresponsive to defibrillation.
Ventricular Tachycardia (VT)Hemodynamic InstabilityRapidly stabilizes the heart’s electrical rhythm in patients with life-threatening, unstable VT.
Atrial Fibrillation (AFib)Rate/Rhythm ControlUsed in acute settings to convert AFib to normal sinus rhythm or to slow a dangerously high heart rate.
Post-Surgical ArrhythmiasCardiac SurgeryPrevents or treats arrhythmias following open-heart surgery.

Mechanism: Multichannel Blockade

Amiodarone works by lengthening the “reset time” of the heart muscle cells, preventing chaotic electrical signals from taking over:

Potassium Channel Blockade (Class III): Its primary effect is delaying the outward potassium current, which prolongs the Action Potential Duration (APD) and the Effective Refractory Period (ERP) in cardiac tissue.

Sodium Channel Blockade (Class I): It slows the upward stroke of the action potential, reducing conduction velocity.

Beta-Blockade (Class II): It non-competitively inhibits alpha and beta receptors, slowing the heart rate and reducing oxygen demand.

Calcium Channel Blockade (Class IV): It inhibits slow calcium channels, further slowing conduction through the Sinoatrial (SA) and Atrioventricular (AV) nodes.

The Pharmacist’s “Technical Warning”

  • The “Slow Loading” Rule: As a pharmacist, I must emphasize that except in cardiac arrest, Amiodarone must be infused slowly. Rapid bolus injection can cause severe Hypotension (low blood pressure) and circulatory collapse.

  • The D5W Mandate: Amiodarone is technically incompatible with Normal Saline (0.9% NaCl) in many concentrations as it can precipitate. It should strictly be diluted in 5% Dextrose (D5W).

  • In-Line Filter: For B2B hospital clients, remind them that an in-line filter is recommended during infusion to catch any microscopic precipitates.

  • PVC Interaction: Amiodarone can leach plasticizers from standard PVC tubing. Ideally, non-PVC (DEHP-free) administration sets should be used for prolonged infusions.

  • Hepatic Toxicity: Acute IV administration has been linked to rapid liver enzyme elevation. Continuous monitoring is required.

The Manufacturer’s Perspective: Technical & Export

From a production and B2B standpoint at your facility in Mumbai:

  • The “Stability & Light” USP: On your digital marketplace, highlight your Amber Ampoule packaging. Amiodarone is light-sensitive; protecting the 150 mg/3 mL solution from UV degradation is a technical hallmark of your WHO-GMP process.

  • The “ACLS Compliance” Advantage: For international emergency medicine tenders, emphasize that your formulation meets the current 2026 ACLS Guidelines for cardiac arrest protocols.

  • Dossier Support: We provide full WHO-standard CTD/eCTD Dossiers for Amiodarone 50 mg/mL injections to support your registration in international tenders for critical care and cardiology.

What are amiodarone tablets used for?

In the pharmaceutical industry, Amiodarone tablets (typically available in 100 mg and 200 mg) are classified as a Class III anti-arrhythmic agent. As a pharmacist, I consider Amiodarone a “broad-spectrum” anti-arrhythmic because, while it is primarily a potassium channel blocker, it also exhibits characteristics of all four Vaughan-Williams classes, making it exceptionally potent for complex cardiac rhythms.

Primary Clinical Uses

  • Ventricular Arrhythmias: Indicated for the treatment of life-threatening recurrent ventricular fibrillation (VF) and hemodynamically unstable ventricular tachycardia (VT).

  • Atrial Fibrillation (AFib): Widely used for rhythm control to convert AFib to a normal sinus rhythm and to maintain that rhythm over the long term.

  • Supraventricular Tachycardias (SVT): Effective in managing various forms of SVT, particularly in patients with impaired left ventricular function where other agents might be contraindicated.

    Refractory Cases: Often utilized when other anti-arrhythmic medications have failed or are not tolerated by the patient.

    Mechanism of Action

Amiodarone’s primary action is the blockade of potassium channels, which prolongs the action potential duration and the refractory period in myocardial tissue (Class III effect). However, it also:

Inhibits inactivated sodium channels (Class I effect).

Exhibits non-competitive alpha- and beta-adrenergic inhibition (Class II effect).

Exhibits weak calcium channel blocking activity (Class IV effect).

This comprehensive blockade helps stabilize the cardiac membrane and slow the conduction of electrical impulses that cause irregular heartbeats.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Amiodarone 200 mg is a critical chronic care molecule requiring strict quality oversight:

  • Lipid Solubility & Bioavailability: Amiodarone is highly lipophilic, which leads to a very long half-life (up to 60 days). As a WHO-GMP manufacturer, we ensure precise formulation to maintain consistent dissolution profiles, which is vital given the drug’s narrow therapeutic index.

  • Photosensitivity & Packaging: The molecule is sensitive to light. We utilize amber-colored PVC or Alu-Alu blister packaging to protect the integrity of the tablets during transit and storage in various global climates.

  • Global Export Niche: Amiodarone is a high-value export item for B2B partners supplying cardiology clinics and hospitals. Our Mumbai-based facility provides the necessary CTD/eCTD Dossiers to facilitate registration in highly regulated and semi-regulated markets.

  • Technical Support: We provide comprehensive stability data for Zone IVb, ensuring that our international partners in Africa, SE Asia, and Latin America receive a product that maintains its potency in hot and humid conditions.

Add to cart